-
2
-
-
84873738342
-
Antineoplastic action and DNA damage effect of Dryopteris
-
W.J. Xue, and X.Y. Du Antineoplastic action and DNA damage effect of Dryopteris Chin. J. Pharmacol. Toxicol. 2 1988 1502 1511
-
(1988)
Chin. J. Pharmacol. Toxicol.
, vol.2
, pp. 1502-1511
-
-
Xue, W.J.1
Du, X.Y.2
-
3
-
-
33747615945
-
Hyperforin, a new lead compound against the progression of cancer and leukemia
-
C. Quiney, C. Billard, C. Salanoubat, J.D. Fourneron, and J.P. Kolb Hyperforin, a new lead compound against the progression of cancer and leukemia Leukemia 20 2006 1519 1525
-
(2006)
Leukemia
, vol.20
, pp. 1519-1525
-
-
Quiney, C.1
Billard, C.2
Salanoubat, C.3
Fourneron, J.D.4
Kolb, J.P.5
-
4
-
-
39549117156
-
Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt
-
C.T. Kuo, M.J. Hsu, B.C. Chen, C.C. Chen, C.M. Teng, S.L. Pan, and C.H. Lin Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt Toxicol. Lett. 177 2008 48 58
-
(2008)
Toxicol. Lett.
, vol.177
, pp. 48-58
-
-
Kuo, C.T.1
Hsu, M.J.2
Chen, B.C.3
Chen, C.C.4
Teng, C.M.5
Pan, S.L.6
Lin, C.H.7
-
5
-
-
78049283700
-
Blocking of PI3K/AKT induces apoptosis by its effect on NF-kB activity in gastric carcinoma cell line SGC7901
-
C. Xu, Z. Jiang, X.Y. Gu, L.J. Meng, and T. Shi Blocking of PI3K/AKT induces apoptosis by its effect on NF-kB activity in gastric carcinoma cell line SGC7901 Biomed. Pharmacother. 64 2010 600 604
-
(2010)
Biomed. Pharmacother.
, vol.64
, pp. 600-604
-
-
Xu, C.1
Jiang, Z.2
Gu, X.Y.3
Meng, L.J.4
Shi, T.5
-
6
-
-
43149102480
-
Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis
-
S. Maddika, S.R. Ande, E. Wiechec, L.L. Hansen, S. Wesselborg, and M. Los Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis J. Cell Sci. 121 2008 979 988
-
(2008)
J. Cell Sci.
, vol.121
, pp. 979-988
-
-
Maddika, S.1
Ande, S.R.2
Wiechec, E.3
Hansen, L.L.4
Wesselborg, S.5
Los, M.6
-
7
-
-
0037017396
-
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: Protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity
-
P.F. Dijkers, K.U. Birkenkamp, E.W. Lam, N.S. Thomas, J.W. Lammers, L. Koenderman, and P.J. Coffer FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity J. Cell Biol. 156 2002 531 542
-
(2002)
J. Cell Biol.
, vol.156
, pp. 531-542
-
-
Dijkers, P.F.1
Birkenkamp, K.U.2
Lam, E.W.3
Thomas, N.S.4
Lammers, J.W.5
Koenderman, L.6
Coffer, P.J.7
-
8
-
-
17144395975
-
The activation of Akt/PKB signaling pathway and cell survival
-
G. Song, G.L. Ouyang, and S.D. Bao The activation of Akt/PKB signaling pathway and cell survival J. Cell Mol. Med. 9 2005 59 71
-
(2005)
J. Cell Mol. Med.
, vol.9
, pp. 59-71
-
-
Song, G.1
Ouyang, G.L.2
Bao, S.D.3
-
9
-
-
23944499155
-
GSK3: An in-Toll-erant protein kinase?
-
J.R. Woodgett, and P.S. Ohashi GSK3: an in-Toll-erant protein kinase? Nat. Immunol. 6 2005 751 752
-
(2005)
Nat. Immunol.
, vol.6
, pp. 751-752
-
-
Woodgett, J.R.1
Ohashi, P.S.2
-
10
-
-
0036235241
-
Expression and regulation of nonsteroidal anti-inflammatory drug activated gene (NAG-1) in human and mouse tissue
-
K.S. Kim, S.J. Baek, G.P. Flake, C.D. Loftin, B.F. Calvo, and T.E. Eling Expression and regulation of nonsteroidal anti-inflammatory drug activated gene (NAG-1) in human and mouse tissue Gastroenterology 122 2002 1388 1398
-
(2002)
Gastroenterology
, vol.122
, pp. 1388-1398
-
-
Kim, K.S.1
Baek, S.J.2
Flake, G.P.3
Loftin, C.D.4
Calvo, B.F.5
Eling, T.E.6
-
11
-
-
84856121293
-
Preparative separation of dryofragin and aspidin BB from Dryopteris fragrans extracts by macroporous resin column chromatography
-
X.J. Li, Y.J. Fu, M. Luo, W. Wang, L. Zhang, C.J. Zhao, and Y.G. Zu Preparative separation of dryofragin and aspidin BB from Dryopteris fragrans extracts by macroporous resin column chromatography J. Pharma. Biomed. 61 2012 199 206
-
(2012)
J. Pharma. Biomed.
, vol.61
, pp. 199-206
-
-
Li, X.J.1
Fu, Y.J.2
Luo, M.3
Wang, W.4
Zhang, L.5
Zhao, C.J.6
Zu, Y.G.7
-
12
-
-
77952668738
-
Naphtho [1, 2-b] furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: Involvement of EGF receptor/PI3K/Akt signaling pathway
-
C.M. Chien, K.L. Lin, J.C. Su, P.W. Chuang, C.H. Tseng, Y.L. Chen, L.S. Chang, and S.R. Lin Naphtho [1, 2-b] furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: Involvement of EGF receptor/PI3K/Akt signaling pathway Eur. J. Pharmacol. 636 2010 52 58
-
(2010)
Eur. J. Pharmacol.
, vol.636
, pp. 52-58
-
-
Chien, C.M.1
Lin, K.L.2
Su, J.C.3
Chuang, P.W.4
Tseng, C.H.5
Chen, Y.L.6
Chang, L.S.7
Lin, S.R.8
-
13
-
-
19444365828
-
The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade
-
Y.F. Liao, Y.C. Hung, W.H. Chang, G.J. Tsay, T.C. Hour, H.C. Hung, and G.Y. Liu The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade Life Sci. 77 2005 707 719
-
(2005)
Life Sci.
, vol.77
, pp. 707-719
-
-
Liao, Y.F.1
Hung, Y.C.2
Chang, W.H.3
Tsay, G.J.4
Hour, T.C.5
Hung, H.C.6
Liu, G.Y.7
-
14
-
-
0033844397
-
Ichthyotoxic phloroglucinol derivatives from Dryopteris fragrans and their antitumor promoting activity
-
H. Ito, T. shimuranaka, K. Mori, Z.X. Jin, H. Tokuda, H. Nishino, and T. Yoshida Ichthyotoxic phloroglucinol derivatives from Dryopteris fragrans and their antitumor promoting activity Chem. Pharm. Bull. 48 2000 11902 11951
-
(2000)
Chem. Pharm. Bull.
, vol.48
, pp. 11902-11951
-
-
Ito, H.1
Shimuranaka, T.2
Mori, K.3
Jin, Z.X.4
Tokuda, H.5
Nishino, H.6
Yoshida, T.7
-
15
-
-
1642617693
-
PI3K/Akt signalling pathway and cancer
-
J.A.V. Fresno, E. Casado, J. de Castro, P. Cejas, C. Belda-Iniesta, and M. González-Barón PI3K/Akt signalling pathway and cancer Cancer Treat. Rev. 30 2004 193 204
-
(2004)
Cancer Treat. Rev.
, vol.30
, pp. 193-204
-
-
Fresno, J.A.V.1
Casado, E.2
De Castro, J.3
Cejas, P.4
Belda-Iniesta, C.5
González-Barón, M.6
-
17
-
-
77951945506
-
Status of PI3K inhibition and biomarker development in cancer therapeutics
-
B. Markman, F. Atzori, J.P. Garcia, W.J. Karolski, A. Ratashak, H.T. Lynch, and T.C. Smyrk Status of PI3K inhibition and biomarker development in cancer therapeutics Ann. Oncol. 21 2010 683 691
-
(2010)
Ann. Oncol.
, vol.21
, pp. 683-691
-
-
Markman, B.1
Atzori, F.2
Garcia, J.P.3
Karolski, W.J.4
Ratashak, A.5
Lynch, H.T.6
Smyrk, T.C.7
-
18
-
-
71549119169
-
Wortmannin potentiates roscovitine-induced growth inhibition in human solid tumor cells by repressing PI3K/Akt pathway
-
F. Zhang, T. Zhang, T. Jiang, R. Zhang, Z.H. Teng, C. Li, Z.P. Gu, and Q.B. Mei Wortmannin potentiates roscovitine-induced growth inhibition in human solid tumor cells by repressing PI3K/Akt pathway Cancer Lett. 286 2009 232 239
-
(2009)
Cancer Lett.
, vol.286
, pp. 232-239
-
-
Zhang, F.1
Zhang, T.2
Jiang, T.3
Zhang, R.4
Teng, Z.H.5
Li, C.6
Gu, Z.P.7
Mei, Q.B.8
-
19
-
-
0037205048
-
The phosphoinositide 3-kinase pathway
-
L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
-
(2002)
Science
, vol.296
, pp. 1655-1657
-
-
Cantley, L.C.1
-
20
-
-
80054718248
-
The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer
-
R. Wendel Naumann The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer Gynecol. Oncol. 123 2011 411 420
-
(2011)
Gynecol. Oncol.
, vol.123
, pp. 411-420
-
-
Wendel Naumann, R.1
-
21
-
-
80054717796
-
Clinical combination of the MEK inhibitor GDC-0973 and the PI3K inhibitor GDC-0941: A first-in-human phase IB study testing daily and intermittent dosing schedules in patients with advanced solid tumors
-
G. Shapiro, P. LoRusso, E. Kwak, J.M. Cleary, L. Musib, C. Jones, A. de Crespigny, M. Belvin, M. McKenzie, M.R. Gates, I.T. Chan, and J.C. Bendell Clinical combination of the MEK inhibitor GDC-0973 and the PI3K inhibitor GDC-0941: a first-in-human phase IB study testing daily and intermittent dosing schedules in patients with advanced solid tumors J. Clin. Oncol. 29 2011 3005
-
(2011)
J. Clin. Oncol.
, vol.29
, pp. 3005
-
-
Shapiro, G.1
Lorusso, P.2
Kwak, E.3
Cleary, J.M.4
Musib, L.5
Jones, C.6
De Crespigny, A.7
Belvin, M.8
McKenzie, M.9
Gates, M.R.10
Chan, I.T.11
Bendell, J.C.12
-
22
-
-
65349155706
-
Induction of Akt activity by chemotherapy confers acquired resistance
-
W.C. Huang, and M.C. Hung Induction of Akt activity by chemotherapy confers acquired resistance J. Formos. Med. Assoc. 108 2009 180 194
-
(2009)
J. Formos. Med. Assoc.
, vol.108
, pp. 180-194
-
-
Huang, W.C.1
Hung, M.C.2
-
23
-
-
4744375264
-
GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression
-
E. Beurel, M. Kornprobst, M.J. Blivet-Van Eggelpoel, C. Ruiz-Ruiz, A. Cadoret, J. Capeau, and C. Desbois-Mouthon GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression Exp. Cell Res. 300 2004 354 364
-
(2004)
Exp. Cell Res.
, vol.300
, pp. 354-364
-
-
Beurel, E.1
Kornprobst, M.2
Blivet-Van Eggelpoel, M.J.3
Ruiz-Ruiz, C.4
Cadoret, A.5
Capeau, J.6
Desbois-Mouthon, C.7
-
24
-
-
0035060429
-
Cyclooxygenase inhibitors regulate the expression of a TGFbeta superfamily member that has proapoptotic and antitumorigenic activities
-
S.J. Baek, K.S. Kim, J.B. Nixon, L.C. Wilson, and T.E. Eling Cyclooxygenase inhibitors regulate the expression of a TGFbeta superfamily member that has proapoptotic and antitumorigenic activities Mol. Pharmacol. 59 2001 901 908
-
(2001)
Mol. Pharmacol.
, vol.59
, pp. 901-908
-
-
Baek, S.J.1
Kim, K.S.2
Nixon, J.B.3
Wilson, L.C.4
Eling, T.E.5
-
25
-
-
10344233656
-
Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells
-
S.J. Baek, J.S. Kim, F.R. Jackson, T.E. Eling, M.F. Mcentee, and S.H. Lee Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells Carcinogenesis 25 2004 2425 2432
-
(2004)
Carcinogenesis
, vol.25
, pp. 2425-2432
-
-
Baek, S.J.1
Kim, J.S.2
Jackson, F.R.3
Eling, T.E.4
McEntee, M.F.5
Lee, S.H.6
-
26
-
-
12844260806
-
Indole-3-carbinol and 3,30-diindolylmethane induce expression of NAG-1 in a p53-independent manner
-
S.H. Lee, J.S. Kim, K. Yamaguchi, T.E. Eling, and S.J. Baek Indole-3-carbinol and 3,30-diindolylmethane induce expression of NAG-1 in a p53-independent manner Biochem. Biophys. Res. Commun. 328 2005 63 69
-
(2005)
Biochem. Biophys. Res. Commun.
, vol.328
, pp. 63-69
-
-
Lee, S.H.1
Kim, J.S.2
Yamaguchi, K.3
Eling, T.E.4
Baek, S.J.5
-
27
-
-
0038118648
-
Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells
-
L.C. Wilson, S.J. Baek, A. Call, and T.E. Eling Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells Int. J. Cancer 105 2003 747 753
-
(2003)
Int. J. Cancer
, vol.105
, pp. 747-753
-
-
Wilson, L.C.1
Baek, S.J.2
Call, A.3
Eling, T.E.4
-
28
-
-
0036201713
-
Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53
-
S.J. Baek, L.C. Wilson, and T.E. Eling Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 Carcinogenesis 23 2002 425 434
-
(2002)
Carcinogenesis
, vol.23
, pp. 425-434
-
-
Baek, S.J.1
Wilson, L.C.2
Eling, T.E.3
-
29
-
-
1342346568
-
Expression of NAG-1, a transforming growth factor-{beta} superfamily member, by troglitazone requires the early growth response gene EGR-1
-
S.J. Baek, J.S. Kim, J.B. Nixon, R.P. DiAugustine, and T.E. Eling Expression of NAG-1, a transforming growth factor-{beta} superfamily member, by troglitazone requires the early growth response gene EGR-1 J. Biol. Chem. 278 2004 6883 6892
-
(2004)
J. Biol. Chem.
, vol.278
, pp. 6883-6892
-
-
Baek, S.J.1
Kim, J.S.2
Nixon, J.B.3
Diaugustine, R.P.4
Eling, T.E.5
-
30
-
-
9644281593
-
Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway
-
K. Yamaguchi, S.H. Lee, T.E. Eling, and S.J. Baek Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway J. Biol. Chem. 279 2004 49617 49623
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 49617-49623
-
-
Yamaguchi, K.1
Lee, S.H.2
Eling, T.E.3
Baek, S.J.4
-
31
-
-
67349160732
-
Caspase-8 in cancer biology and therapy
-
S. Fulda Caspase-8 in cancer biology and therapy Cancer Lett. 281 2009 128 133
-
(2009)
Cancer Lett.
, vol.281
, pp. 128-133
-
-
Fulda, S.1
-
32
-
-
0842281645
-
Cell death: Critical control points
-
N.N. Danial, and S.J. Korsmeyer Cell death: critical control points Cell 116 2004 205 219
-
(2004)
Cell
, vol.116
, pp. 205-219
-
-
Danial, N.N.1
Korsmeyer, S.J.2
-
33
-
-
78149294004
-
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
-
T. Zaremba, H. Thomas, M. Cole, E.R. Plummer, and N.J. Curtin Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials Cancer Chemother. Pharm. 66 2010 807 812
-
(2010)
Cancer Chemother. Pharm.
, vol.66
, pp. 807-812
-
-
Zaremba, T.1
Thomas, H.2
Cole, M.3
Plummer, E.R.4
Curtin, N.J.5
|